Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

Guoshuang Xu, Kai Liu, Judy Anderson, Kenneth Patrene, Suzanne Lentzsch, G. David Roodman, Hongjiao Ouyang

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

BM stromal cells (BMSCs) are key players in the microenvironmental support of multiple myeloma (MM) cell growth and bone destruction. A spliced form of the X-box-binding protein-1 (XBP1s), a major proximal effector of unfolded protein response signaling, is highly expressed in MM cells and plays an indispensable role in MM pathogenesis. In the present study, we found that XBP1s is induced in the BMSCs of the MM microenvironment. XBP1s overexpression in healthy human BMSCs enhanced gene and/or protein expression of VCAM-1, IL-6, and receptor activator of NF-ΚB ligand (RANKL), enhancing BMSC support of MM cell growth and osteoclast formation in vitro and in vivo. Conversely, deficiency of XBP1 in healthy donor BMSCs displayed a range of effects on BMSCs that were opposite to those cells with overexpression of XBP1s. Knock-down of XBP1 in MM patient BMSCs greatly compromised their increased VCAM-1 protein expression and IL-6 and RANKL secretion in response to TNFαand reversed their enhanced support of MM-cell growth and osteoclast formation. Our results demonstrate that XBP1s is a pathogenic factor underlying BMSC support of MM cell growth and osteoclast formation and therefore represents a therapeutic target for MM bone disease.

Original languageEnglish (US)
Pages (from-to)4205-4214
Number of pages10
JournalBlood
Volume119
Issue number18
DOIs
StatePublished - May 3 2012
Externally publishedYes

Fingerprint

Cell growth
Osteoclasts
Multiple Myeloma
Mesenchymal Stromal Cells
Stromal Cells
Carrier Proteins
Bone
Growth
Vascular Cell Adhesion Molecule-1
Interleukin-6 Receptors
Proteins
Unfolded Protein Response
X-Box Binding Protein 1
Bone Diseases
Bone Development
Interleukin-6
Genes
Ligands
Tissue Donors

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation. / Xu, Guoshuang; Liu, Kai; Anderson, Judy; Patrene, Kenneth; Lentzsch, Suzanne; Roodman, G. David; Ouyang, Hongjiao.

In: Blood, Vol. 119, No. 18, 03.05.2012, p. 4205-4214.

Research output: Contribution to journalArticle

Xu, Guoshuang ; Liu, Kai ; Anderson, Judy ; Patrene, Kenneth ; Lentzsch, Suzanne ; Roodman, G. David ; Ouyang, Hongjiao. / Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation. In: Blood. 2012 ; Vol. 119, No. 18. pp. 4205-4214.
@article{ea1d5d20b77f42d7b497913e10f29090,
title = "Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation",
abstract = "BM stromal cells (BMSCs) are key players in the microenvironmental support of multiple myeloma (MM) cell growth and bone destruction. A spliced form of the X-box-binding protein-1 (XBP1s), a major proximal effector of unfolded protein response signaling, is highly expressed in MM cells and plays an indispensable role in MM pathogenesis. In the present study, we found that XBP1s is induced in the BMSCs of the MM microenvironment. XBP1s overexpression in healthy human BMSCs enhanced gene and/or protein expression of VCAM-1, IL-6, and receptor activator of NF-ΚB ligand (RANKL), enhancing BMSC support of MM cell growth and osteoclast formation in vitro and in vivo. Conversely, deficiency of XBP1 in healthy donor BMSCs displayed a range of effects on BMSCs that were opposite to those cells with overexpression of XBP1s. Knock-down of XBP1 in MM patient BMSCs greatly compromised their increased VCAM-1 protein expression and IL-6 and RANKL secretion in response to TNFαand reversed their enhanced support of MM-cell growth and osteoclast formation. Our results demonstrate that XBP1s is a pathogenic factor underlying BMSC support of MM cell growth and osteoclast formation and therefore represents a therapeutic target for MM bone disease.",
author = "Guoshuang Xu and Kai Liu and Judy Anderson and Kenneth Patrene and Suzanne Lentzsch and Roodman, {G. David} and Hongjiao Ouyang",
year = "2012",
month = "5",
day = "3",
doi = "10.1182/blood-2011-05-353300",
language = "English (US)",
volume = "119",
pages = "4205--4214",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "18",

}

TY - JOUR

T1 - Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

AU - Xu, Guoshuang

AU - Liu, Kai

AU - Anderson, Judy

AU - Patrene, Kenneth

AU - Lentzsch, Suzanne

AU - Roodman, G. David

AU - Ouyang, Hongjiao

PY - 2012/5/3

Y1 - 2012/5/3

N2 - BM stromal cells (BMSCs) are key players in the microenvironmental support of multiple myeloma (MM) cell growth and bone destruction. A spliced form of the X-box-binding protein-1 (XBP1s), a major proximal effector of unfolded protein response signaling, is highly expressed in MM cells and plays an indispensable role in MM pathogenesis. In the present study, we found that XBP1s is induced in the BMSCs of the MM microenvironment. XBP1s overexpression in healthy human BMSCs enhanced gene and/or protein expression of VCAM-1, IL-6, and receptor activator of NF-ΚB ligand (RANKL), enhancing BMSC support of MM cell growth and osteoclast formation in vitro and in vivo. Conversely, deficiency of XBP1 in healthy donor BMSCs displayed a range of effects on BMSCs that were opposite to those cells with overexpression of XBP1s. Knock-down of XBP1 in MM patient BMSCs greatly compromised their increased VCAM-1 protein expression and IL-6 and RANKL secretion in response to TNFαand reversed their enhanced support of MM-cell growth and osteoclast formation. Our results demonstrate that XBP1s is a pathogenic factor underlying BMSC support of MM cell growth and osteoclast formation and therefore represents a therapeutic target for MM bone disease.

AB - BM stromal cells (BMSCs) are key players in the microenvironmental support of multiple myeloma (MM) cell growth and bone destruction. A spliced form of the X-box-binding protein-1 (XBP1s), a major proximal effector of unfolded protein response signaling, is highly expressed in MM cells and plays an indispensable role in MM pathogenesis. In the present study, we found that XBP1s is induced in the BMSCs of the MM microenvironment. XBP1s overexpression in healthy human BMSCs enhanced gene and/or protein expression of VCAM-1, IL-6, and receptor activator of NF-ΚB ligand (RANKL), enhancing BMSC support of MM cell growth and osteoclast formation in vitro and in vivo. Conversely, deficiency of XBP1 in healthy donor BMSCs displayed a range of effects on BMSCs that were opposite to those cells with overexpression of XBP1s. Knock-down of XBP1 in MM patient BMSCs greatly compromised their increased VCAM-1 protein expression and IL-6 and RANKL secretion in response to TNFαand reversed their enhanced support of MM-cell growth and osteoclast formation. Our results demonstrate that XBP1s is a pathogenic factor underlying BMSC support of MM cell growth and osteoclast formation and therefore represents a therapeutic target for MM bone disease.

UR - http://www.scopus.com/inward/record.url?scp=84860829155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860829155&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-05-353300

DO - 10.1182/blood-2011-05-353300

M3 - Article

C2 - 22427205

AN - SCOPUS:84860829155

VL - 119

SP - 4205

EP - 4214

JO - Blood

JF - Blood

SN - 0006-4971

IS - 18

ER -